Watermark

BGB-A317-15025-101

Active, not recruiting

BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-15025-101

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20212721

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents